US2023181792A1PendingUtilityA1
Methods of producing an osteoinductive calcium phosphate material for bone grafting
Assignee: SECADA MEDICAL LLC DBA VENTRIS MEDICAL LLCPriority: Mar 24, 2020Filed: Nov 21, 2022Published: Jun 15, 2023
Est. expiryMar 24, 2040(~13.7 yrs left)· nominal 20-yr term from priority
A61L 27/12A61L 2430/02A61L 27/3608A61L 27/54A61L 27/50A61L 2300/102A61L 27/3691A61L 2400/12A61L 2300/11A61L 27/3687
75
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to methods for producing biphasic calcium phosphate materials using chemical processing methods including exposure to peroxides. The resulting materials exhibit an osteoinductive needle-like surface morphology and are useful as artificial bone grafts.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for inducing bone tissue formation in a patient, the method comprising:
providing granules for implantation in a patient, the granules comprising hydroxyapatite (HA) and β-tricalcium phosphate (β-TCP), wherein the granules have been soaked in a solution comprising an oxidizing agent to produce one or more HA needle or nanorod protrusions from the granules’ surface.
2 . The method of claim 1 wherein, prior to the soaking step, the granules have been hydrothermally treated.
3 . The method of claim 2 wherein the hydrothermal treatment comprises autoclaving the granules at about 140° C.
4 . The method of claim 3 wherein the granule has been autoclaved at about 140° C. for about 8 hours.
5 . The method of claim 4 wherein the granules have been dried between autoclaving and soaking.
6 . The method of claim 2 wherein the granules comprise about 60% HA and about 40% β-TCP.
7 . The method of claim 6 wherein the oxidizing agent is hydrogen peroxide (H 2 O 2 ).
8 . The method of claim 7 wherein the solution comprises about 50% H 2 O 2 .
9 . The method of claim 8 wherein the granules have been soaked in a sealed container for about 6 hours.
10 . The method of claim 2 wherein the hydrothermal treatment comprises autoclaving the granules at a temperature less than 125° C.
11 . The method of claim 10 wherein the granules comprise about 20% HA and about 80% β-TCP.
12 . The method of claim 11 wherein the peroxide is hydrogen peroxide (H 2 O 2 ).
13 . The method of claim 12 wherein the solution comprises about 30% H 2 O 2 .
14 . The method of claim 13 wherein the granules have been soaked in a sealed container for about 4 hours.
15 . The method of claim 1 comprising providing the granules for implantation as a bone graft.
16 . The method of claim 1 comprising providing the granules for implantation to promote wound healing.
17 . The method of claim 1 comprising providing the granules for implantation in a maxillofacial procedure.
18 . The method of claim 1 comprising providing the granules in a putty or paste format.
19 . The method of claim 1 comprising providing the granules as a solid block of material.
20 . The method of claim 19 comprising trimming the solid block of material to fit a bone defect in the patient.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.